SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is currently trending following a $75 million direct offering to an institutional investor, intended to fully fund its Phase 3 MASH trial, which has sparked mixed community reactions concerning dilution versus strategic positioning. This capital raise, coupled with a new 'Overweight' rating and $20 price target from Barclays and recent FDA Breakthrough Therapy Designation for pemvidutide, is fueling intense speculation around a potential short squeeze, partnership, or outright acquisition within the MASH and weight loss sector.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending significantly following reports that China has approved the import of its H200 AI chips, sparking widespread bullish sentiment. The community is actively discussing a potential substantial rally, with many anticipating the stock to break key resistance levels and reach new highs. This optimism is fueled by strong AI demand and upcoming big tech earnings, though some traders are wary of past volatility related to similar news.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is experiencing a significant upward momentum, driven by continued tech sector strength, early positive mega-cap earnings, and a weakening dollar pushing it towards new all-time highs. The market community is sharply divided between fomo-driven bulls celebrating 

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is experiencing significant market attention as investors keenly await its earnings, propelled by expectations of massive bookings and optimistic analyst outlooks tied to the accelerating AI-driven semiconductor demand and robust capital expenditure plans from key customers. While many laud its crucial near-monopoly in advanced chipmaking, the community also debates its high valuation and the long-term implications of rising geopolitical tensions and reports of China's indigenous EUV technology development. The company remains a central figure in the broader chip equipment sector, reflecting confidence in the ongoing AI supercycle.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending due to a significant market reaction following a proposed lower-than-anticipated Medicare Advantage payment rate for 2027, rather than its recent earnings. This development has ignited fierce debate among investors, with many viewing the sell-off as an overreaction and a generational buying opportunity, while others anticipate continued pressure on UNH and the broader healthcare sector amid regulatory uncertainty and speculation of market manipulation.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is experiencing a significant rally to new all-time highs, driven by growing community concerns over a weakening US dollar and increasing national debt, alongside broader geopolitical uncertainties. Investors are actively discussing a rotation into precious metals as a secure hedge, with many predicting substantial further gains while a minority cautiously eye a potential correction after the rapid ascent.

Stride, Inc. is a technology-based educational company, which engages in the provision of proprietary and third-party curriculum, software systems and educational services. It also offers online curriculum and career services to middle and high school students, under the Destinations Career Academy brand name. The company was founded by Ronald J. Packard in 2000 and is headquartered in Reston, VA.

Stride Inc

Stride Inc. is trending strongly following an impressive earnings report that surpassed estimates with significant enrollment growth, particularly in Career Learning. The company also authorized a substantial stock repurchase program, sparking widespread community discussion about its undervalued position. Many are now discussing a potential short squeeze, given previous short interest and the company's strong performance in the expanding digital education space.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is experiencing heightened investor interest following BlackRock's increased stake and the FDA's new flexibility on manufacturing requirements, which could expedite its BLA submission. The community is actively discussing the potential for significant partnerships or a buyout, driven by the company's promising oncology pipeline, particularly CAN-2409, amid a broader biopharma M&A surge to address looming patent cliffs. Many believe shorts are trapped due to low liquidity, signaling potential for upward price movement.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending following its strategic acquisition of SkyWater Technology, a move seen by many as establishing the first vertically integrated, U.S.-based quantum computing platform. This development is sparking intense community discussion, with proponents highlighting potential national security contracts and an accelerated qubit roadmap, while some express concerns about shareholder dilution and the sector's current commercialization timeline. The integration aims to secure a domestic supply chain, positioning the company as a key player in the quantum supremacy race.

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Aaron Leabman in January 2018 and is headquartered in Pleasanton, CA.

Movano Inc

Movano ($MOVE) is trending as its partner, Corvex, secured a long-term NVIDIA H200 GPU deployment, positioning the company in the burgeoning AI and cloud computing sector. Community discussion heavily emphasizes its exceptionally low share float, currently protected from immediate dilution, as a prime setup for a significant short squeeze, drawing comparisons to other recent low-float runners.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Rating of "Moderate Buy" by Analysts

Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the ten research firms that are presently covering the company, MarketBeat.com...

Sivik Global Healthcare LLC Purchases 95,000 Shares of Surgery Partners, Inc. $SGRY

Sivik Global Healthcare LLC lifted its holdings in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 76.0% during the 3rd quarter, according to its most recent filing with the Securities...

Surgery Partners, Inc. $SGRY Stake Lessened by Voya Investment Management LLC

Voya Investment Management LLC lessened its holdings in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 86.5% in the 3rd quarter, according to the company in its most recent disclosure with the...

Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Recommendation of "Moderate Buy" by Brokerages

Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) has been given a consensus rating of "Moderate Buy" by the ten research firms that are covering the firm, MarketBeat.com reports. One analyst...

Squarepoint Ops LLC Cuts Stock Position in Surgery Partners, Inc. $SGRY

Squarepoint Ops LLC trimmed its position in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 74.5% during the second quarter, according to the company in its most recent 13F filing with the...

Caxton Associates LLP Decreases Stock Holdings in Surgery Partners, Inc. $SGRY

Caxton Associates LLP reduced its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 43.5% in the second quarter, according to its most recent filing with the SEC. The fund...

Surgery Partners Announces $425 Mln Add-On Senior Notes Offering

(RTTNews) - Surgery Partners, Inc. (SGRY), a major operator of short-stay surgical facilities, announced that its wholly owned subsidiary, Surgery Center Holdings, Inc., plans to issue an additional...

Surgery Partners (NASDAQ:SGRY) Shares Down 5.4% - Time to Sell?

Surgery Partners (NASDAQ:SGRY) Stock Price Down 5.4% - Here's What Happened...

Norges Bank Purchases Shares of 1,196,983 Surgery Partners, Inc. $SGRY

Norges Bank acquired a new position in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities...

GABELLI & Co INVESTMENT ADVISERS INC. Buys 68,400 Shares of Surgery Partners, Inc. $SGRY

GABELLI & Co INVESTMENT ADVISERS INC. lifted its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 87.9% in the second quarter, according to the company in its most recent...

Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.

Current Price	$15.30
Prev Close	$16.20
Open	$16.11
Dividend Yield	0.00%
50-Day Moving Average	$15.97
Beta	1.12
Avg. Volume	1.78M
PE Ratio	-11.29

52-Week High	$26.16
52-Week Low	$14.94
Market Capitalization	$2.1B
EPS (Annual)	-$1.33
Price to Book	1.14
Revenue Per Employee	$207,620.00
Enterprise Value/EBITDA	N/A

SGRY
Surgery Partners Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SGRY News

SGRYSurgery Partners Inc